Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Goldschmidt · SciRah

Researcher profile · Semantic Scholar

N. Goldschmidt

Share profile

N. Goldschmidt — researcher profile on SciRah

h-index: 31
Works: 154
Citations: 5,807

Most-cited papers

Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
J. Kuruvilla, R. Ramchandren, A. Santoro, E. Paszkiewicz-Kozik +18 more
2021The Lancet Oncology228 citations
Semantic Scholar
Treatment Strategies, Outcomes, and Prognostic Factors in 291 Patients with Secondary CNS Involvement by Diffuse Large B-Cell Lymphoma
T. El-Galaly, C. Cheah, M. Bendtsen, Grzegorz S. Nowakowski +30 more
2018European Journal of Cancer123 citations Open access
Semantic Scholar
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Andrea B. Moffitt +55 more
2017Cell112 citations Open access
Semantic Scholar
Daratumumab resistance is frequent in advanced‐stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis
M. Pick, V. Vainstein, N. Goldschmidt, D. Lavie +6 more
2018European Journal of Haematology83 citations
Semantic Scholar
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
M. Fürstenau, A. Kater, S. Robrecht, J. von Tresckow +43 more
2024The Lancet Oncology69 citations Open access
Semantic Scholar
Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance
Drirh Khare, N. Goldschmidt, Aya Bardugo, Devorah Gur-Wahnon +2 more
2017PLoS ONE64 citations Open access
Semantic Scholar
Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
O. Benjamini, L. Rokach, G. Itchaki, A. Braester +14 more
2021Haematologica63 citations Open access
Semantic Scholar
Deformability of transfused red blood cells is a potent determinant of transfusion‐induced change in recipient's blood flow
G. Barshtein, A. Pries, N. Goldschmidt, Ayelet Zukerman +4 more
2016Microcirculation55 citations
Semantic Scholar
Characteristics of primary splenic diffuse large B‐cell lymphoma and role of splenectomy in improving survival
O. Bairey, L. Shvidel, C. Perry, E. Dann +3 more
2015Cancer47 citations Open access
Semantic Scholar
Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow‐up for patients with no residual mass
Eldad J. Dann, L. Berkahn, T. Mashiach, Michael Frumer +5 more
2014British Journal of Haematology44 citations Open access
Semantic Scholar
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
M. Fürstenau, Yvonne J. Thus, S. Robrecht, C. Mellink +43 more
2023Blood37 citations Open access
Semantic Scholar
Deformability of transfused red blood cells is a potent effector of transfusion‐induced hemoglobin increment: A study with β‐thalassemia major patients
G. Barshtein, N. Goldschmidt, A. Pries, O. Zelig +2 more
2017American journal of hematology/oncology36 citations Open access
Semantic Scholar
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients
E. Dann, O. Bairey, R. Bar-Shalom, T. Mashiach +16 more
2017British Journal of Haematology35 citations
Semantic Scholar
Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis
N. Goldschmidt, Leora Zamir, A. Poperno, N. R. Kahan +1 more
2016Journal of the American Board of Family Medicine35 citations Open access
Semantic Scholar
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: primary analysis of the ELM-1 study
Max S. Topp, M. Matasar, J. Allan, S. Ansell +15 more
2024Blood33 citations Open access
Semantic Scholar
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
Y. Segman, E. Ribakovsky, A. Avigdor, Yair Goldhecht +21 more
2020Leukemia and Lymphoma32 citations
Semantic Scholar
Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group
T. Tadmor, L. Shvidel, O. Bairey, N. Goldschmidt +8 more
2014American journal of hematology/oncology32 citations Open access
Semantic Scholar
Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse
N. Goldschmidt, N. Horowitz, Vered Heffes, F. Darawshy +4 more
2019Leukemia and Lymphoma31 citations
Semantic Scholar
Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
Jacob Vine, Sara Cohen, R. Ruchlemer, N. Goldschmidt +7 more
2014Leukemia and Lymphoma30 citations
Semantic Scholar
KEYNOTE-204: Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) in relapsed or refractory classic Hodgkin lymphoma (R/R cHL).
J. Kuruvilla, R. Ramchandren, A. Santoro, E. Paszkiewicz-Kozik +16 more
2020Journal of Clinical Oncology29 citations
Semantic Scholar
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes
D. Noerenberg, F. Briest, C. Hennch, Kenichi Yoshida +29 more
2023Journal of Clinical Oncology25 citations
Semantic Scholar
Early lymphocyte collection for anti‐CD19 CART production improves T‐cell fitness in patients with relapsed/refractory diffuse large B‐cell lymphoma
T. D. Sharon, M. Assayag, B. Avni, S. Kfir-Erenfeld +6 more
2023British Journal of Haematology24 citations Open access
Semantic Scholar
CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma
Ariel Agur, G. Amir, O. Paltiel, M. Klein +3 more
2015Leukemia and Lymphoma24 citations
Semantic Scholar
Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report
M. Mei-Zahav, H. Blau, E. Bruckheimer, E. Zur +1 more
2017Journal of Otolaryngology - Head and Neck Surgery22 citations Open access
Semantic Scholar
Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy
N. Goldschmidt, G. Kleinstern, M. Orevi, O. Paltiel +5 more
2016Cancer Chemotherapy and Pharmacology20 citations
Semantic Scholar
Glofitamab in Combination with Polatuzumab Vedotin Maintains Durable Responses and a Manageable Safety Profile in Patients with Heavily Pre-Treated Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL) Including High-Grade B-Cell Lymphoma (HGBCL): Extended Follow-up of a Phase Ib/II Study
Martin Hutchings, A. Sureda Balari, F. Bosch, T. Larsen +17 more
2024Blood18 citations Open access
Semantic Scholar
Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience
Y. Herishanu, N. Goldschmidt, O. Bairey, R. Ruchlemer +9 more
2015Haematologica18 citations Open access
Semantic Scholar
Trichothiodystrophy
Satish R. Raj, S. R. Wayne Chen, R. Sheldon, A. Shah +114 more
2020Definitions17 citations Open access
Semantic Scholar
Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial
M. Mei-Zahav, Y. Gendler, E. Bruckheimer, D. Prais +4 more
2020Journal of Clinical Medicine17 citations Open access
Semantic Scholar
A Randomized Controlled Study to Determine the Efficacy of Garlic Compounds in Patients With Hematological Malignancies at Risk for Chemotherapy-Related Febrile Neutropenia
M. Gatt, J. Strahilevitz, N. Sharon, D. Lavie +4 more
2015Integrative Cancer Therapies17 citations Open access
Semantic Scholar
Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
Y. Herishanu, Adir Shaulov, R. Fineman, S. Bašić-Kinda +53 more
2020American journal of hematology/oncology14 citations Open access
Semantic Scholar
MicroRNAs as predictors for CNS relapse of systemic diffuse large B-cell lymphoma
N. Pillar, O. Bairey, N. Goldschmidt, Y. Fellig +6 more
2017OncoTarget14 citations Open access
Semantic Scholar
First-Line Venetoclax Combinations in Fit Patients with CLL: 4-Year Follow-up and NGS-Based MRD Analysis from the Phase 3 GAIA/CLL13 Trial
M. Fürstenau, M. Ritgen, S. Robrecht, J. von Tresckow +43 more
2023Blood13 citations Open access
Semantic Scholar
Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study
Yael Morgenstern, S. Aumann, N. Goldschmidt, M. Gatt +2 more
2021Cancer Medicine13 citations Open access
Semantic Scholar
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma
B. Nachmias, Adir Shaulov, D. Lavie, N. Goldschmidt +4 more
2019Acta Haematologica13 citations
Semantic Scholar
Hairy Cell Leukemia: Retrospective Analysis of Demographic Data and Outcome of 203 Patients from 12 Medical Centers in Israel
M. Inbar, Y. Herishanu, N. Goldschmidt, O. Bairey +12 more
2018Anticancer Research13 citations Open access
Semantic Scholar
Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment
M. Gentile, T. Shanafelt, F. Mauro, G. Reda +33 more
2018European Journal of Haematology12 citations Open access
Semantic Scholar
Leukocyte blood count during early puerperium and its relation to puerperal infection†
U. Dior, L. Kogan, U. Elchalal, N. Goldschmidt +3 more
2014Journal of Maternal-Fetal & Neonatal Medicine12 citations
Semantic Scholar
Odronextamab Demonstrates Durable Complete Responses in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Progressing after CAR-T Therapy: Outcomes from the ELM-1 Study
J. Crombie, M. Matasar, M. Topp, J. Allan +15 more
2023Blood9 citations
Semantic Scholar
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol
M. Mittelman, K. Filanovsky, Y. Ofran, H. Rosenbaum +8 more
2016Annals of Hematology9 citations
Semantic Scholar
Thymidine kinase levels correlate with prognosis in aggressive lymphoma and can discriminate patients with a clinical suspicion of indolent to aggressive transformation.
M. Gatt, N. Goldschmidt, I. Kalichman, M. Friedman +2 more
2015Anticancer Research9 citations
Semantic Scholar
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
T. Berger, T. Shochat, S. Aumann, B. Nachmias +10 more
2023Annals of Hematology8 citations
Semantic Scholar
GLOFITAMAB PLUS POLATUZUMAB VEDOTIN DEMONSTRATES DURABLE RESPONSES AND A MANAGEABLE SAFETY PROFILE IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
M. Hutchings, A. Avigdor, A. Sureda, M. Terol +18 more
2023Hematological Oncology7 citations Open access
Semantic Scholar
A retrospective study of 222 patients with newly diagnosed primary central nervous system lymphoma—Outcomes indicative for improved survival overtime
O. Bairey, E. Lebel, C. Buxbaum, T. Porges +7 more
2023Hematological Oncology6 citations
Semantic Scholar
Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups
Jenny Zhang, Anupama Reddy, C. Love, Andrea B. Moffitt +39 more
20166 citations
Semantic Scholar
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin’s lymphoma patients
B. Nachmias, Veronica Sandler, Elena Slyusarevsky, Galina Pogrebijski +4 more
2019Annals of Hematology5 citations
Semantic Scholar
Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials
E. Joffe, N. Goldschmidt, O. Bairey, R. Fineman +10 more
2018European Journal of Haematology5 citations
Semantic Scholar
Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib
N. Goldschmidt, D. Rund
2017Leukemia and Lymphoma5 citations
Semantic Scholar
Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients.
G. Karavani, Koral Vedder, Einat Gutman-Ido, Raizl Gruda Sussman +4 more
2023Human Reproduction4 citations
Semantic Scholar
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma
E. Lebel, N. Goldschmidt, T. Siegal, A. Lossos +13 more
2022Leukemia and Lymphoma4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Tadmor×12
Invite
T. Tadmor — researcher profile on SciRah
M. Gatt×11
Invite
M. Gatt — researcher profile on SciRah
O. Bairey×11
Invite
O. Bairey — researcher profile on SciRah
L. Shvidel×8
Invite
L. Shvidel — researcher profile on SciRah

×8

Invite

R. Ruchlemer — researcher profile on SciRah

Y. Herishanu×8

Invite

Y. Herishanu — researcher profile on SciRah

Invite

D. Lavie — researcher profile on SciRah

Invite

A. Polliack — researcher profile on SciRah

Adir Shaulov×6

Invite

Adir Shaulov — researcher profile on SciRah

Invite

A. Gural — researcher profile on SciRah

Invite

R. Fineman — researcher profile on SciRah

Invite

O. Paltiel — researcher profile on SciRah